A study to find genes that might increase or reduce the risk of bowel cancer (CORGI 2)

Cancer type:

Bowel (colorectal) cancer
Colon cancer
Rectal cancer

Status:

Open

Phase:

Other

Researchers will look at samples of blood and tissue from people who have cancer and people who haven’t had cancer.

This study builds on a previous study of the research team called CORGI that is now closed. 

More about this trial

We know from research that certain genetic factors you inherit from your parents may affect your risk of getting tumours in your bowel. This includes non cancerous (benign Open a glossary item) tumours such as polyps  Open a glossary itemand adenomas, as well as bowel cancer.

In this study, the researchers will look at the genes of a large number of people in 3 groups. They will look for common genetic factors that may increase or reduce the risk of developing bowel cancer.

The first group of people have, or have had:

  • bowel cancer
  • a non cancerous bowel tumour such as polyps
  • another cancer that might be related to bowel cancer

This is the index patient group.

The second group are relatives by birth (blood relatives) of the index patient group.

The third group called the control group, are people who don’t have cancer.

The aims of the study are to:

  • identify genes that might increase or decrease the risk of bowel cancer
  • understand why bowel cancer might develop

Taking part in the study won’t affect any treatment you might have. You won’t benefit from taking part. The researchers hope that the results of this study will help people in the future.

Who can enter

The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.

There are 3 groups in this study the:

  • index patient group
  • blood relative group
  • control group

Index patient group
You may be able to join this study if you are older than 6 years and have or had one of the following:

  • bowel cancer
  • a non cancerous (benign) bowel condition such as polyps
  • another cancer, such as endometrial cancer, that might be related to bowel cancer

Blood relative group
You may be able to join if you are over 18 years old and are a relative by birth (blood relative) of someone in the index patient group.

Control group
You may be able to join if you are over 18 years old and are:

  • not a blood relative, such as sister in law or brother in law, of someone from the index patient group
  • an individual who has never had cancer

Who can’t join this study
You can’t join this study as part of the control group if your father, mother, brother or sister (first degree relative) has or had bowel cancer.

Trial design

The study team need 5,000 people to join.

You fill in a short questionnaire. The questions are about your:

  • medical details
  • family history
  • diagnosis and hospital treatment, if relevant

You can ignore any question if you want to and not answer it.

You have a sample of blood taken. This can be done at the hospital by the doctor, nurse or member of the study team. Or your GP or Practice Nurse can take it.

If you have had cancer the study team will ask for a piece of tissue from when you were first diagnosed. They will also ask for a piece of tissue if in the future you have further surgery, tissue samples (biopsies Open a glossary item) or tests. 

They may also ask if they can contact you about any future research which you might be able to take part in.

You don’t have to agree to the samples or the future research if you don’t want to. 

Hospital visits

There are no extra hospital visits if you take part in this study.

Side effects

There are no side effects.

Location

Belfast
Birmingham
Bristol
Cambridge
Exeter
Harrow
Isleworth
Leeds
Leicester
Liverpool
London
Manchester
Middlesbrough
Newcastle upon Tyne
Nottingham
Oxford
Southampton
Sutton

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Ian Tomlinson

Supported by

Cancer Research UK
European Commission
University of Birmingham 

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

15321

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think